EGFR-targeted granzyme B expressed in NK cells enhances natural cytotoxicity and mediates specific killing of tumor cells
- Sprache
-
Englisch
- Identifier
-
1081035986
Thema
Krebs; Onkologie
Beteiligte Personen und Organisationen
Oberoi, Pranav
Jabulowsky, Robert Alexander
Bähr-Mahmud, Hayat
Wels, Winfried S.
Jabulowsky, Robert Alexander
Bähr-Mahmud, Hayat
Wels, Winfried S.
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
26.01.2023, 13:53 MEZ
Beteiligte
- Oberoi, Pranav
- Jabulowsky, Robert Alexander
- Bähr-Mahmud, Hayat
- Wels, Winfried S.
Ähnliche Objekte (12)
Bispecific costimulatory molecules for activation of tumor-killing lymphocytes
Hypoxia enhances the antiglioma cytotoxicity of b10, a glycosylated derivative of betulinic acid
Phospholipid metabolites in recurrent glioblastoma : in vivo markers detect different tumor phenotypes before and under antiangiogenic therapy
ASA404, a vascular disrupting agent, as an experimental treatment approach for brain tumors
Tumor-associated macrophages, angiogenesis, and tumor cell migration in oral squamous cell carcinoma
Vitamin D3 receptor is highly expressed in Hodgkin's lymphoma
Bevacizumab for patients with recurrent gliomas presenting with a gliomatosis cerebri growth pattern
Bevacizumab for patients with recurrent multifocal glioblastomas
Myoinositol as a biomarker in recurrent glioblastoma treated with bevacizumab : a 1H-magnetic resonance spectroscopy study
Long-term tumor remission under trastuzumab treatment for HER2 positive metastatic breast cancer – results from the HER-OS patient registry
Cytotoxicity and infiltration of human NK cells in in vivo-like tumor spheroids
Funktioneller Status und Alltagsbewältigung bei Patienten mit fortgeschrittenen gastrointestinalen Tumoren im Verlauf einer Chemotherapie
Bispecific costimulatory molecules for activation of tumor-killing lymphocytes
Hypoxia enhances the antiglioma cytotoxicity of b10, a glycosylated derivative of betulinic acid
Phospholipid metabolites in recurrent glioblastoma : in vivo markers detect different tumor phenotypes before and under antiangiogenic therapy
ASA404, a vascular disrupting agent, as an experimental treatment approach for brain tumors
Tumor-associated macrophages, angiogenesis, and tumor cell migration in oral squamous cell carcinoma
Vitamin D3 receptor is highly expressed in Hodgkin's lymphoma
Bevacizumab for patients with recurrent gliomas presenting with a gliomatosis cerebri growth pattern
Bevacizumab for patients with recurrent multifocal glioblastomas
Myoinositol as a biomarker in recurrent glioblastoma treated with bevacizumab : a 1H-magnetic resonance spectroscopy study
Long-term tumor remission under trastuzumab treatment for HER2 positive metastatic breast cancer – results from the HER-OS patient registry
Cytotoxicity and infiltration of human NK cells in in vivo-like tumor spheroids
Funktioneller Status und Alltagsbewältigung bei Patienten mit fortgeschrittenen gastrointestinalen Tumoren im Verlauf einer Chemotherapie
Bispecific costimulatory molecules for activation of tumor-killing lymphocytes
Hypoxia enhances the antiglioma cytotoxicity of b10, a glycosylated derivative of betulinic acid
Phospholipid metabolites in recurrent glioblastoma : in vivo markers detect different tumor phenotypes before and under antiangiogenic therapy
ASA404, a vascular disrupting agent, as an experimental treatment approach for brain tumors
Tumor-associated macrophages, angiogenesis, and tumor cell migration in oral squamous cell carcinoma
Vitamin D3 receptor is highly expressed in Hodgkin's lymphoma
Bevacizumab for patients with recurrent gliomas presenting with a gliomatosis cerebri growth pattern
Bevacizumab for patients with recurrent multifocal glioblastomas
Myoinositol as a biomarker in recurrent glioblastoma treated with bevacizumab : a 1H-magnetic resonance spectroscopy study
Long-term tumor remission under trastuzumab treatment for HER2 positive metastatic breast cancer – results from the HER-OS patient registry
Cytotoxicity and infiltration of human NK cells in in vivo-like tumor spheroids